Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-06

Clinical Trial Update: Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis [Phase 3]

View source ↗

Summary

This document provides a clinical trial update for a Phase 3 long-term extension study of filgotinib in adults with ulcerative colitis, which is currently activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Filgotinib (filgotinib)

Snippet

Sponsor: Alfasigma S.p.A. | Conditions: Ulcerative Colitis | Phase 3 | Status: ACTIVE_NOT_RECRUITING